Literature DB >> 24288407

Causal role for JAK2 V617F in thrombosis.

Angela G Fleischman1, Jeffrey W Tyner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24288407      PMCID： PMC3843232          DOI： 10.1182/blood-2013-10-531665

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Myeloproliferative neoplasms and thrombosis.

Authors:  Tiziano Barbui; Guido Finazzi; Anna Falanga
Journal:  Blood       Date:  2013-07-03       Impact factor: 22.113

Review 2.  The biology of PECAM-1.

Authors:  P J Newman
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

3.  The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome.

Authors:  Selcuk Sozer; Maria Isabel Fiel; Thomas Schiano; Mingjiang Xu; John Mascarenhas; Ronald Hoffman
Journal:  Blood       Date:  2009-03-17       Impact factor: 22.113

4.  Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status.

Authors:  Eduardo Arellano-Rodrigo; Alberto Alvarez-Larrán; Juan Carlos Reverter; Neus Villamor; Dolors Colomer; Francisco Cervantes
Journal:  Haematologica       Date:  2006-02       Impact factor: 9.941

5.  Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F.

Authors:  Virginia M Zaleskas; Daniela S Krause; Katherine Lazarides; Nihal Patel; Yiguo Hu; Shaoguang Li; Richard A Van Etten
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

6.  JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia.

Authors:  Catherine M Hobbs; Harriet Manning; Cavan Bennett; Louella Vasquez; Sonia Severin; Lauren Brain; Alexandra Mazharian; Jose A Guerrero; Juan Li; Nicole Soranzo; Anthony R Green; Steve P Watson; Cedric Ghevaert
Journal:  Blood       Date:  2013-10-01       Impact factor: 22.113
  6 in total
  7 in total

Review 1.  Toward platelet transcriptomics in cancer diagnosis, prognosis and therapy.

Authors:  Anandi Krishnan; Sally Thomas
Journal:  Br J Cancer       Date:  2021-11-22       Impact factor: 9.075

2.  JAK2V617F: Is It Sufficient as a Single Player in Splanchnic Venous Thrombosis?

Authors:  Pratibha Dhiman; Priyanka Saxena
Journal:  Case Rep Hematol       Date:  2015-03-24

3.  Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study.

Authors:  R Dambrauskienė; R Gerbutavičius; R Ugenskienė; R Jankauskaitė; A Savukaitytė; R Šimoliūnienė; M Rudžianskienė; R Gerbutavičienė; E Juozaitytė
Journal:  Balkan J Med Genet       Date:  2017-06-30       Impact factor: 0.519

Review 4.  Clonal hematopoietic mutations linked to platelet traits and the risk of thrombosis or bleeding.

Authors:  Alicia Veninga; Ilaria De Simone; Johan W M Heemskerk; Hugo Ten Cate; Paola E J van der Meijden
Journal:  Haematologica       Date:  2020-06-18       Impact factor: 9.941

5.  Janus Kinase-2 V617F Mutation and Antiphospholipid Syndrome in Cerebral Sinus Venous Thrombosis: Natural History and Retrospective Bicenter Analysis.

Authors:  David Orion; Ze'ev Itsekson-Hayosh; Shlomi Peretz; Rom Mendel; Gal Yaniv; Moshe Attia; Drorit Grizim-Merkel
Journal:  Front Neurol       Date:  2022-04-14       Impact factor: 4.086

6.  The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.

Authors:  Chiara Baldini; Francesca Romana Moriconi; Sara Galimberti; Peter Libby; Raffaele De Caterina
Journal:  Eur Heart J       Date:  2021-11-07       Impact factor: 35.855

7.  Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis.

Authors:  Dawn Maze; Sajida Kazi; Vikas Gupta; Ann Kinga Malinowski; Rouhi Fazelzad; Prakesh S Shah; Nadine Shehata
Journal:  JAMA Netw Open       Date:  2019-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.